AutoGen Introduces the NeXTRACT 48

AutoGen introduces a new addition to their instrumentation portfolio, the NeXTRACT 48, a fully automated workflow for extracting viral DNA and RNA.   Holliston, MA, December 15, 2020: Autogen, Inc. is pleased to announce the introduction of their newest fully automated workflow, the NeXTRACT 48. The NeXTRACT 48 is designed for the rapid extraction of…

AutoGen Releases New Saliva Protocol for FlexSTAR Platforms

Developed in collaboration with DNA Genotek Inc., the new protocol can process up to 30, 4 ml of saliva collected with an Oragene® device in a single well. Holliston, MA, December 1, 2020: AutoGen Inc. is pleased to announce the launch of a new laboratory-based saliva sample processing protocol for their portfolio of FlexSTAR workflows.…

AutoGen Launches Upgrade to FlexSTAR Platforms

The new AutoGen vortex module upgrade enables a 35% improvement in throughput Holliston, MA, September 16, 2020: AutoGen Inc. is excited to announce the launch of the vortex module upgrade to their portfolio of FlexSTAR workflows. FlexSTAR workflows are fully automated instruments for isolating genomic DNA from large volumes of whole blood, buffy coats, saliva,…

AutoGen COVID-19 Update May 2020

Dear Colleagues, Thank you for your support and patience as the number of cases and countries impacted by COVID-19 increases each day. AutoGen continues to be fully operational while still practicing safe social distancing both in and out of the office during this ongoing pandemic. We are working closely with our supply chain partners to…

IMPORTANT – AutoGen COVID-19 Update

Dear Colleagues, We at AutoGen continue to monitor the global COVID-19 pandemic and above all else are committed to protecting the health, safety and well-being of our employees, customers and partners. The spread of the COVID-19 virus presents unique challenges and our actions are intended to promote social distancing and enable continuity of services in…

Webinar | The Transformation of the Lab to Fight Pediatric Genetic Illnesses

Thank you to everyone who participated in our recent webinar, The Transformation of the Lab to Fight Genetic Illnesses in the Amish and Mennonite Populations. Please click here to view the webinar video.

CEO Michael Messier featured in CEOCFO Magazine

AutoGen19-CEOCFOMagazine-Interview Interview conducted by: Lynn Fosse, Senior Editor, CEOCFO Magazine, Published – September 16, 2019 CEOCFO: Mr. Messier, what is the focus for AutoGen, today? Mr. Messier: AutoGen’s primary focus is to provide optimal workflows for automated nucleic acid extractions with an unmatched level of customer support and service. Our customers include biorepositories, contract research…

AutoGen Launches The XTRACT 16+®

AutoGen is excited to announce a recent expansion in their instrumentation portfolio with the launch of another fully automated workflow, the XTRACT 16+®. Holliston, MA, May 10, 2019: Introducing AutoGen’s newest fully automated workflow, the XTRACT 16+®, this versatile instrumentation provides fast and high-quality DNA or RNA from all molecular diagnostic, biological, clinical, and forensic…